Elevated neutrophil count emerged as an independent risk factor, aligning with prior studies showing peripheral neutrophilia and NLRP3 (NOD-, LPR- and pyrin domain-containing protein 3) inflammasome activation contribute to AD pathology (Jose et al., 2022; Xu et al., 2025). Here, CYGB is linked to Alzheimer disease.